Cerus Corp
NASDAQ:CERS

Watchlist Manager
Cerus Corp Logo
Cerus Corp
NASDAQ:CERS
Watchlist
Price: 2.74 USD Market Closed
Market Cap: 526.3m USD
Section:
 

Relative Value

The Relative Value of one CERS stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.74 USD, Cerus Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CERS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
49
vs Industry
57
Median 3Y
1.7
Median 5Y
2.3
Industry
2.4
Forward
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-13.2
Median 5Y
-16.1
Industry
22.9
Forward
-33.6
More Details
147.6
P/OCF
P/OCF
Price to OCF
147.6
vs History
0
vs Industry
15
Median 3Y
-9.9
Median 5Y
-22.4
Industry
14.7
More Details
319.7
P/FCFE
P/FCFE
Price to FCFE
319.7
vs History
0
vs Industry
5
Median 3Y
-9.9
Median 5Y
-25.2
Industry
21.4
More Details
8.6
P/B
P/B
Price to Book Value
8.6
vs History
46
vs Industry
16
Median 3Y
6.4
Median 5Y
8.5
Industry
2.3
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
47
vs Industry
59
Median 3Y
1.7
Median 5Y
2.1
Industry
2.6
Forward
2.2
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
46
vs Industry
67
Median 3Y
2.7
Median 5Y
3.5
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-20.1
Industry
12.3
Forward
48.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-19
Median 5Y
-18.4
Industry
17.2
Forward
-61.3
More Details
139.2
EV/OCF
EV/OCF
Enterprise Value to OCF
139.2
vs History
0
vs Industry
17
Median 3Y
-9.5
Median 5Y
-20.4
Industry
15
More Details
2 954.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
2 954.3
vs History
0
vs Industry
15
Median 3Y
-8.2
Median 5Y
-20
Industry
19
More Details
4.5
EV/IC
EV/IC
Enterprise Value to IC
4.5
vs History
55
vs Industry
18
Median 3Y
3.3
Median 5Y
5
Industry
1.9
More Details

Multiples Across Competitors

CERS Competitors Multiples
Cerus Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cerus Corp
NASDAQ:CERS
526.2m USD 2.3 -33 -61.1 -52.3
JP
Hoya Corp
TSE:7741
8.6T JPY 9.7 41.2 25.5 30.6
CH
Alcon AG
SIX:ALC
31.5B CHF 3.9 37.5 15.7 30.5
US
Medline Inc
NASDAQ:MDLN
34.7B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
130B DKK 4.7 35.8 16.3 19.4
US
Align Technology Inc
NASDAQ:ALGN
12.5B USD 3.1 33 15 19
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.7B CNY 10 27.7 25.1 25.1
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP 2.8 30 224.3 364.6
CA
Bausch + Lomb Corp
NYSE:BLCO
6.2B USD 1.2 -20.2 19.9 93.8
CH
Ypsomed Holding AG
SIX:YPSN
4.6B CHF 5.8 23.7 15.4 20.9
JP
Asahi Intecc Co Ltd
TSE:7747
790.7B JPY 6.3 52.2 22.9 33.3
P/E Multiple
Earnings Growth PEG
US
Cerus Corp
NASDAQ:CERS
Average P/E: 35.1
Negative Multiple: -33 		N/A N/A
JP
Hoya Corp
TSE:7741
41.2
13%
3.2
CH
Alcon AG
SIX:ALC
37.5
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
35.8
22%
1.6
US
Align Technology Inc
NASDAQ:ALGN
33
27%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.7
10%
2.8
UK
ConvaTec Group PLC
LSE:CTEC
30
33%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -20.2 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
23.7
34%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
52.2
35%
1.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cerus Corp
NASDAQ:CERS
Average EV/EBITDA: 42.2
Negative Multiple: -61.1 		N/A N/A
JP
Hoya Corp
TSE:7741
25.5
11%
2.3
CH
Alcon AG
SIX:ALC
15.7
8%
2
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
16.3
8%
2
US
Align Technology Inc
NASDAQ:ALGN
15
13%
1.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.1
15%
1.7
UK
ConvaTec Group PLC
LSE:CTEC
224.3
10%
22.4
CA
Bausch + Lomb Corp
NYSE:BLCO
19.9
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
15.4
21%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
22.9
10%
2.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cerus Corp
NASDAQ:CERS
Average EV/EBIT: 70.8
Negative Multiple: -52.3 		N/A N/A
JP
Hoya Corp
TSE:7741
30.6
N/A N/A
CH
Alcon AG
SIX:ALC
30.5
23%
1.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
19.4
8%
2.4
US
Align Technology Inc
NASDAQ:ALGN
19
15%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.1
11%
2.3
UK
ConvaTec Group PLC
LSE:CTEC
364.6
22%
16.6
CA
Bausch + Lomb Corp
NYSE:BLCO
93.8
60%
1.6
CH
Ypsomed Holding AG
SIX:YPSN
20.9
29%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
33.3
N/A N/A

See Also

Summary
CERS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CERS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CERS stock valuation using valuation multiples.
Wall Street Estimates
CERS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CERS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.